<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<title>SB 544 (Edition 1)</title>
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:"Times New \(W1\)";}
@font-face
	{font-family:IDAutomationHC39M;
	panose-1:2 0 5 9 0 0 0 2 0 4;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoToc1, li.MsoToc1, div.MsoToc1
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
p.MsoToc2, li.MsoToc2, div.MsoToc2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:12.25pt;
	margin-bottom:.0001pt;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;}
p.MsoToc3, li.MsoToc3, div.MsoToc3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:23.75pt;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{mso-style-link:"Header Char";
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{mso-style-link:"Footer Char";
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.MsoLineNumber
	{font-family:"Times New Roman",serif;}
p.LMSBase, li.LMSBase, div.LMSBase
	{mso-style-name:LMSBase;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aArticle, li.aArticle, div.aArticle
	{mso-style-name:aArticle;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aArticleTitle, li.aArticleTitle, div.aArticleTitle
	{mso-style-name:aArticleTitle;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aBase, li.aBase, div.aBase
	{mso-style-name:aBase;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aBillSection, li.aBillSection, div.aBillSection
	{mso-style-name:aBillSection;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:.75in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aBlock1, li.aBlock1, div.aBlock1
	{mso-style-name:aBlock1;
	mso-style-link:"aBlock1 Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.25in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-.5in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aBlock2, li.aBlock2, div.aBlock2
	{mso-style-name:aBlock2;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.75in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-.5in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aBlock3, li.aBlock3, div.aBlock3
	{mso-style-name:aBlock3;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.25in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-.5in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aBlock4, li.aBlock4, div.aBlock4
	{mso-style-name:aBlock4;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.75in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-.5in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aBlock5, li.aBlock5, div.aBlock5
	{mso-style-name:aBlock5;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:3.25in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-.5in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aChapter, li.aChapter, div.aChapter
	{mso-style-name:aChapter;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.aHeading, li.aHeading, div.aHeading
	{mso-style-name:aHeading;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
p.aLongTitle, li.aLongTitle, div.aLongTitle
	{mso-style-name:aLongTitle;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-.25in;
	font-size:12.0pt;
	font-family:"Times New \(W1\)";
	text-transform:uppercase;}
p.aMargin1, li.aMargin1, div.aMargin1
	{mso-style-name:aMargin1;
	mso-style-link:"aMargin1 Char";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:.25in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aMargin2, li.aMargin2, div.aMargin2
	{mso-style-name:aMargin2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:.75in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aPart, li.aPart, div.aPart
	{mso-style-name:aPart;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aSection, li.aSection, div.aSection
	{mso-style-name:aSection;
	mso-style-link:"aSection Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-.75in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.aSP, li.aSP, div.aSP
	{mso-style-name:aSP;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	color:blue;
	font-weight:bold;}
p.aSPComment, li.aSPComment, div.aSPComment
	{mso-style-name:aSPComment;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New \(W1\)";
	color:red;
	display:none;
	font-weight:bold;}
p.aSPFunds1, li.aSPFunds1, div.aSPFunds1
	{mso-style-name:aSPFunds1;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aSPFunds2, li.aSPFunds2, div.aSPFunds2
	{mso-style-name:aSPFunds2;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aSPFundsHeading1, li.aSPFundsHeading1, div.aSPFundsHeading1
	{mso-style-name:aSPFundsHeading1;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.aSPFundsHeading2, li.aSPFundsHeading2, div.aSPFundsHeading2
	{mso-style-name:aSPFundsHeading2;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.aSPHeading, li.aSPHeading, div.aSPHeading
	{mso-style-name:aSPHeading;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-1.0in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
p.nonumber, li.nonumber, div.nonumber
	{mso-style-name:nonumber;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aSPHeadingLine, li.aSPHeadingLine, div.aSPHeadingLine
	{mso-style-name:aSPHeadingLine;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.ASPlist, li.ASPlist, div.ASPlist
	{mso-style-name:ASPlist;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.5in;
	margin-bottom:.0001pt;
	text-indent:-1.75in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aSPRequestedBY, li.aSPRequestedBY, div.aSPRequestedBY
	{mso-style-name:aSPRequestedBY;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New \(W1\)";}
p.aSPTitle, li.aSPTitle, div.aSPTitle
	{mso-style-name:aSPTitle;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-.25in;
	font-size:12.0pt;
	font-family:"Times New \(W1\)";
	text-transform:uppercase;
	font-weight:bold;}
p.aSubChapter, li.aSubChapter, div.aSubChapter
	{mso-style-name:aSubChapter;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
p.aSubPart, li.aSubPart, div.aSubPart
	{mso-style-name:aSubPart;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aTitle, li.aTitle, div.aTitle
	{mso-style-name:aTitle;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.cHistoryNote
	{mso-style-name:cHistoryNote;}
span.FooterChar
	{mso-style-name:"Footer Char";
	mso-style-link:Footer;
	font-family:"Times New Roman",serif;}
span.HeaderChar
	{mso-style-name:"Header Char";
	mso-style-link:Header;
	font-family:"Times New Roman",serif;}
p.TOCPageHeader, li.TOCPageHeader, div.TOCPageHeader
	{mso-style-name:TOCPageHeader;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
p.aSPSubTitle, li.aSPSubTitle, div.aSPSubTitle
	{mso-style-name:aSPSubTitle;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-.25in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
p.aSPHeadingMiscellaneous, li.aSPHeadingMiscellaneous, div.aSPHeadingMiscellaneous
	{mso-style-name:aSPHeadingMiscellaneous;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-1.0in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
p.aDistrict, li.aDistrict, div.aDistrict
	{mso-style-name:aDistrict;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.aBlock1Char
	{mso-style-name:"aBlock1 Char";
	mso-style-link:aBlock1;
	font-family:"Times New Roman",serif;}
span.aMargin1Char
	{mso-style-name:"aMargin1 Char";
	mso-style-link:aMargin1;
	font-family:"Times New Roman",serif;}
span.aSectionChar
	{mso-style-name:"aSection Char";
	mso-style-link:aSection;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
.MsoChpDefault
	{font-family:"Calibri",sans-serif;}
.MsoPapDefault
	{margin-bottom:10.0pt;
	line-height:115%;}
 /* Page Definitions */
 @page WordSection1
	{size:8.5in 11.0in;
	margin:.6in .9in .5in 1.2in;}
div.WordSection1
	{page:WordSection1;}
-->
</style>

</head>

<body lang=EN-US>

<div class=WordSection1>

<p class=nonumber align=center style='margin-top:24.0pt;text-align:center'><b>GENERAL
ASSEMBLY OF NORTH CAROLINA</b></p>

<p class=nonumber align=center style='margin-top:3.0pt;margin-right:0in;
margin-bottom:6.0pt;margin-left:0in;text-align:center'><b>SESSION 2019</b></p>

<p class=nonumber align=left style='text-align:left'><b>S                                                                                                                                                     1</b></p>

<p class=nonumber align=center style='text-align:center'><b>SENATE BILL 544</b></p>

<p class=nonumber align=center style='text-align:center'><b>&nbsp;</b></p>

<p class=nonumber align=center style='text-align:center'><b>&nbsp;</b></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width=0
 style='width:6.55in;margin-left:-5.75pt;border-collapse:collapse;border:none'>
 <tr>
  <td width=527 colspan=2 valign=top style='width:395.25pt;border:none;
  border-bottom:solid windowtext 1.0pt;padding:0in .05in 0in 5.4pt'>
  <p class=nonumber align=left style='margin-bottom:6.0pt;text-align:left'>Short
  Title:      Establish Non-Opioid Treatment Alternatives.</p>
  </td>
  <td width=102 valign=top style='width:76.35pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0in .05in 0in 5.4pt'>
  <p class=nonumber align=right style='margin-bottom:6.0pt;text-align:right'>(Public)</p>
  </td>
 </tr>
 <tr>
  <td width=96 valign=top style='width:71.85pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0in .05in 0in 5.4pt'>
  <p class=nonumber align=left style='margin-top:3.0pt;margin-right:0in;
  margin-bottom:3.0pt;margin-left:0in;text-align:left'>Sponsors:</p>
  </td>
  <td width=533 colspan=2 valign=top style='width:399.75pt;border:none;
  border-bottom:solid windowtext 1.0pt;padding:0in .05in 0in 5.4pt'>
  <p class=nonumber style='margin-top:3.0pt;margin-right:0in;margin-bottom:
  3.0pt;margin-left:0in'>Senator Hise (Primary Sponsor).</p>
  </td>
 </tr>
 <tr>
  <td width=96 valign=top style='width:71.85pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0in .05in 0in 5.4pt'>
  <p class=nonumber align=left style='margin-top:3.0pt;margin-right:0in;
  margin-bottom:3.0pt;margin-left:0in;text-align:left'>Referred to:</p>
  </td>
  <td width=533 colspan=2 valign=top style='width:399.75pt;border:none;
  border-bottom:solid windowtext 1.0pt;padding:0in .05in 0in 5.4pt'>
  <p class=nonumber style='margin-top:3.0pt;margin-right:0in;margin-bottom:
  3.0pt;margin-left:0in'>Rules and Operations of the Senate</p>
  </td>
 </tr>
 <tr height=0>
  <td width=96 style='border:none'></td>
  <td width=431 style='border:none'></td>
  <td width=102 style='border:none'></td>
 </tr>
</table>

<p class=nonumber align=center style='margin-top:6.0pt;margin-right:0in;
margin-bottom:12.0pt;margin-left:0in;text-align:center'>April 3, 2019</p>

<p class=aBase align=center style='text-align:center'><span style='color:black'>A
BILL TO BE ENTITLED</span></p>

<p class=aLongTitle><span style='font-family:"Times New Roman",serif;
color:black'>AN ACT directing health care providers to initiate acute or
chronic pain management care with non&#8209;opioid treatment alternatives,
whenever possible; directing the department of health and human services to
develop and make available on its internet web site a uniform voluntary non&#8209;opioid
directive form; establishing a process for patients to voluntarily elect non&#8209;opioid
pain management care; and establishing insurance coverage for non&#8209;opioid
pain management care.</span></p>

<p class=aBase><span style='color:black'>The General Assembly of North Carolina
enacts:</span></p>

<p class=aBase><span style='background:yellow'>&nbsp;</span></p>

<p class=aHeading>PART I. NON&#8209;OPIOID DIRECTIVE FOR PROVIDERS OF PAIN
MANAGEMENT CARE</p>

<p class=aBillSection><b><span style='color:black'>SECTION 1.1.</span></b><span
style='color:black'>  G.S.&nbsp;90&#8209;106 reads as rewritten:</span></p>

<p class=aSection><span style='color:black;font-weight:normal'>&quot;</span><span
style='color:black'>§ 90&#8209;106.  Prescriptions and labeling.</span></p>

<p class=aMargin1><span style='color:black'>…</span></p>

<p class=aMargin1><span style='color:black'>(a3)      Limitation on
Prescriptions Upon Initial Consultation for Acute <u>or Chronic </u>Pain. – <s>A
</s><u>Upon the initial consultation and treatment of a patient for acute or
chronic pain, a practitioner, as a first line of treatment, shall provide the
patient with a referral to, or a prescription for, any of the following
alternatives to targeted controlled substances, when appropriate:</u></span></p>

<p class=aBlock1><u><span style='color:black'>(1)</span></u><span
style='color:black'>        <u>Acupuncture.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(2)</span></u><span
style='color:black'>        <u>Chiropractic care.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(3)</span></u><span
style='color:black'>        <u>Massage therapy.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(4)</span></u><span
style='color:black'>        <u>Occupational therapy.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(5)</span></u><span
style='color:black'>        <u>Osteopathic manipulative treatment.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(6)</span></u><span
style='color:black'>        <u>Physical therapy.</u></span></p>

<p class=aMargin1><u><span style='color:black'>In managing treatment for a
patient's acute or chronic pain, a practitioner shall, whenever possible,
administer nonpharmacological modalities or medications that are less addictive
alternatives to targeted controlled substances.</span></u></p>

<p class=aMargin1><u><span style='color:black'>If a </span></u><span
style='color:black'>practitioner <u>determines that a targeted controlled
substance is the appropriate treatment modality for a patient for acute pain, the
practitioner </u>may not prescribe more than a five&#8209;day supply of any
targeted controlled substance upon the initial consultation and treatment of <s>a
</s><u>the </u>patient for acute pain, unless the prescription is for post&#8209;operative
acute pain relief for use immediately following a surgical procedure. A
practitioner shall not prescribe more than a seven&#8209;day supply of any
targeted controlled substance for post&#8209;operative acute pain relief
immediately following a surgical procedure. Upon any subsequent consultation
for the same pain, the practitioner may issue any appropriate renewal, refill,
or new prescription for a targeted controlled <s>substance. </s><u>substance
after evaluating the appropriateness of nonpharmacological modalities or
medications that are less addictive alternatives to targeted controlled
substances. </u>This subsection does not apply to prescriptions for controlled
substances issued by a practitioner who orders a controlled substance to be wholly
administered in a hospital, nursing home licensed under Chapter 131E of the
General Statutes, hospice facility, <s>or </s>residential care facility, as
defined in <s>G.S.&nbsp;14&#8209;32.2(c1). This subsection does not apply to
prescriptions for controlled substances issued by a practitioner who orders a
controlled substance to be wholly administered in an </s><u>G.S.&nbsp;14&#8209;32.2(c1),
</u>emergency facility, veterinary hospital, or animal hospital, as defined in
G.S.&nbsp;90&#8209;181.1. A practitioner who acts in accordance with the
limitation on prescriptions as set forth in this subsection <s>shall be </s><u>is
</u>immune from any civil liability or disciplinary action from the
practitioner's occupational licensing agency for acting in accordance with this
subsection.</span></p>

<p class=aMargin1><span style='color:black'>(a4)      Definitions. – As used in
<s>this subsection, </s><u>subsection (a3) of this section, </u>the following
terms have the following meanings:</span></p>

<p class=aBlock1><span style='color:black'>(1)        Acute pain. – Pain,
whether resulting from disease, accident, intentional trauma, or other cause,
that the practitioner reasonably expects to last for three months or less. The
term does not include chronic pain or pain being treated as part of cancer
care, hospice care, palliative care, or medication&#8209;assisted treatment for
substance use disorder. The term does not include pain being treated as part of
cancer care, hospice care, or palliative care provided by a person licensed to
practice veterinary medicine pursuant to Article 11 of Chapter 90 of the
General Statutes.</span></p>

<p class=aBlock1><span style='color:black'>(2)        Chronic pain. – Pain that
typically lasts for longer than three months or that lasts beyond the time of
normal tissue healing.</span></p>

<p class=aBlock1><span style='color:black'>(3)        Surgical procedure. – A
procedure that is performed for the purpose of structurally altering the human
body by incision or destruction of tissues as part of the practice of medicine
or a procedure that is performed for the purpose of structurally altering the
animal body by incision or destruction of tissues as part of the practice of
veterinary medicine. This term includes the diagnostic or therapeutic treatment
of conditions or disease processes by use of instruments such as lasers,
ultrasound, ionizing, radiation, scalpels, probes, or needles that cause
localized alteration or transportation of live human tissue, or live animal
tissue in the practice of veterinary medicine, by cutting, burning, vaporizing,
freezing, suturing, probing, or manipulating by closed reduction for major
dislocations and fractures, or otherwise altering by any mechanical, thermal,
light&#8209;based, electromagnetic, or chemical means.</span></p>

<p class=aMargin1><span style='color:black'>….&quot;</span></p>

<p class=aBase>&nbsp;</p>

<p class=aHeading>PART II. PATIENT&#8209;INITIATED NON&#8209;OPIOID DIRECTIVE
FOR PAIN MANAGEMENT CARE</p>

<p class=aBillSection><b><span style='color:black'>SECTION 2.1.</span></b><span
style='color:black'>(<b>a)</b>  Article 1B of Chapter 90 of the General
Statutes is amended by adding a new section to read:</span></p>

<p class=aSection><span style='color:black;font-weight:normal'>&quot;</span><u><span
style='color:black'>§ 90&#8209;21.17A.  Voluntary non&#8209;opioid directives; official
form.</span></u></p>

<p class=aMargin1><u><span style='color:black'>(a)</span></u><span
style='color:black'>        <u>Definitions. – The following definitions apply
in this Article:</u></span></p>

<p class=aBlock1><u><span style='color:black'>(1)</span></u><span
style='color:black'>        <u>Commission. – The Commission for Mental Health,
Developmental Disabilities, and Substance Abuse Services.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(2)</span></u><span
style='color:black'>        <u>Department. – The Department of Health and Human
Services.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(3)</span></u><span
style='color:black'>        <u>Health care provider. – An individual who is
licensed to prescribe, administer, dispense, or distribute controlled
substances, or a representative or agent of that individual.</u></span></p>

<p class=aBlock1><a name=3><u><span style='color:black'>(4)</span></u><span
style='color:black'>        <u>Patient representative. – Any of the following:</u></span></a></p>

<p class=aBlock2><u><span style='color:black'>a.</span></u><span
style='color:black'>         <u>In the case of a minor, a parent with custody
of the minor or the legal guardian or legal custodian of the minor.</u></span></p>

<p class=aBlock2><u><span style='color:black'>b.</span></u><span
style='color:black'>         <u>In all other cases, a legal guardian, or a
health care agent as defined in G.S.&nbsp;32A&#8209;16.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(b)</span></u><span
style='color:black'>        <u>Uniform Voluntary Non&#8209;Opioid Directive
Form. – The Department, in consultation with the Commission for Mental Health,
Developmental Disabilities, and Substance Abuse Services, the North Carolina
Medical Board, and the North Carolina Board of Pharmacy, shall develop a
uniform non&#8209;opioid directive form that indicates to all prescribing
health care providers that the named patient shall not be offered, prescribed,
supplied with, or otherwise administered an opioid medication. The Department
shall make the form easily accessible on its Internet Web site, in a format
that can be downloaded or copied.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(c)</span></u><span
style='color:black'>        <u>Voluntary Execution and Filing of Patient&#8209;Initiated
Form. – A patient may exercise the right to elect non&#8209;opioid
prescriptions and treatment by voluntarily executing and filing a uniform
voluntary non&#8209;opioid directive form with a health care provider or other
person authorized by the Department to accept and file the form. The patient may
exercise this right by signing and dating the form in the presence of the
health care provider or other authorized person. In the case of a patient who
is unable to voluntarily execute and file the form on the patient's own behalf,
a duly authorized patient representative may exercise this right on behalf of a
patient by executing and filing the form in accordance with this section. Each
health care provider or other person authorized by the Department to accept a
uniform voluntary non&#8209;opioid directive form for filing shall date and
affix his or her signature to the form in the presence of the patient or a duly
authorized patient representative as evidence of acceptance, and provide a copy
of the form to the patient or duly authorized patient representative, as
appropriate.</u></span></p>

<p class=aMargin1><u><span style='color:black'>Prior to signing the form, a
health care provider may, as the health care provider deems appropriate, assess
the patient's personal and family history of alcohol or drug abuse and evaluate
the patient's risk for medication misuse or abuse. In evaluating the patient's
risk for medication misuse or abuse, the health care provider shall review the
information in the controlled substances reporting system, established under Article
5E of this Chapter, pertaining to the patient. If a health care provider
reasonably believes that a patient is at risk for opioid misuse or abuse or
that, in the health care provider's professional medical judgment, a non&#8209;opioid
directive is appropriate for a patient, then the health care provider shall date
and affix his or her signature to the form in the presence of the patient or a
duly authorized patient representative as evidence of acceptance, and provide a
copy of the form to the patient.</span></u></p>

<p class=aMargin1><u><span style='color:black'>(d)</span></u><span
style='color:black'>       <u>Effect of Form. – In managing treatment for a
patient's pain, a health care provider shall, whenever possible, honor the
patient's voluntary non&#8209;opioid directive form by administering less
addictive, non&#8209;opioid medications or nonpharmacological modalities as a
first line of treatment.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(e)</span></u><span
style='color:black'>        <u>Revocation of Form. – A patient may for any
reason revoke, verbally or in writing, a uniform voluntary non&#8209;opioid
directive form by notifying a health care provider or other person authorized
by the Department to accept and file the form. The health care provider or
other authorized person shall document the revocation in the patient's medical
record.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(f)</span></u><span
style='color:black'>        <u>Rules. – The Department, in consultation with
the Commission for Mental Health, Developmental Disabilities, and Substance
Abuse Services, the North Carolina Medical Board, and the North Carolina Board
of Pharmacy, shall adopt rules establishing all of the following:</u></span></p>

<p class=aBlock1><u><span style='color:black'>(1)</span></u><span
style='color:black'>        <u>A list of persons, in addition to health care
providers, who are authorized to accept and file uniform voluntary non&#8209;opioid
directive forms and notices of revocation.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(2)</span></u><span
style='color:black'>        <u>A standard form for the recording and
transmission of voluntary non&#8209;opioid directive forms, which at a minimum shall
(i) include space for verification of the non&#8209;opioid directive by the
patient's health care provider and (ii) meet the applicable confidentiality
requirements of the Health Insurance Portability and Accountability Act of 1996
(HIPAA), as amended.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(3)</span></u><span
style='color:black'>        <u>Procedures for recording a voluntary non&#8209;opioid
directive form in the patient's medical record.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(4)</span></u><span
style='color:black'>        <u>Procedures for a patient to revoke his or her
own duly executed and filed voluntary non&#8209;opioid directive form.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(5)</span></u><span
style='color:black'>        <u>Requirements and procedures for a patient
representative to override a duly executed and filed voluntary non&#8209;opioid
directive form.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(6)</span></u><span
style='color:black'>        <u>Circumstances under which an attending health
care provider may override a duly executed and filed voluntary non&#8209;opioid
directive form based on documented and professional medical judgment, which
shall be recorded in the patient's medical record.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(7)</span></u><span
style='color:black'>        <u>Procedures to ensure that any recording,
sharing, or distribution of data relative to the voluntary non&#8209;opioid
directive form complies with all federal and State confidentiality laws.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(8)</span></u><span
style='color:black'>        <u>Appropriate exemptions for health care providers
and emergency medical personnel to prescribe or administer opioid medications
when, in their professional medical judgment, an opioid medication is
necessary.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(9)</span></u><span
style='color:black'>        <u>Continuing education requirements for health
care providers that include, at a minimum, requirements for completing not less
than four hours annually on effective alternatives to the use of opioids that
focus on the use of nonpharmacological modalities for pain management,
specifically acupuncture, chiropractic care, massage therapy, occupational
therapy, osteopathic manipulative treatment, and physical therapy.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(g)</span></u><span
style='color:black'>        <u>Immunity for Pharmacists. – Each written or
electronic prescription for a controlled substance that is presented or
transmitted to a pharmacy subject to the requirements of G.S.&nbsp;90&#8209;85.21
or G.S.&nbsp;90&#8209;85.21A is presumed valid for purposes of this section. No
pharmacist licensed to practice in this State shall be held in violation of
this section for dispensing a controlled substance containing an opioid or
other controlled substance that contradicts a voluntary non&#8209;opioid
directive form, except upon evidence that the pharmacist acted knowingly
against the voluntary non&#8209;opioid directive form.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(h)</span></u><span
style='color:black'>        <u>Civil and Criminal Immunity for Health Care
Providers. – No health care provider shall be subject to criminal prosecution,
civil liability, or disciplinary action by an occupational licensing agency for
any of the following:</u></span></p>

<p class=aBlock1><u><span style='color:black'>(1)</span></u><span
style='color:black'>        <u>Failure to offer, prescribe, dispense, or
administer a controlled substance containing an opioid medication to a patient
in good&#8209;faith reliance on a voluntary non&#8209;opioid directive form
executed in accordance with this section, if both of the following are true:</u></span></p>

<p class=aBlock2><u><span style='color:black'>a.</span></u><span
style='color:black'>         <u>There are no reasonable grounds for the health
care provider to doubt the validity of the voluntary non&#8209;opioid directive
form or the identity of the patient.</u></span></p>

<p class=aBlock2><u><span style='color:black'>b.</span></u><span
style='color:black'>         <u>The health care provider does not have actual
knowledge of the patient's revocation of the voluntary non&#8209;opioid
directive form.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(2)</span></u><span
style='color:black'>        <u>Failure to follow a voluntary non&#8209;opioid
directive form executed in accordance with this section if the health care
provider had no actual knowledge of the existence of the voluntary non&#8209;opioid
directive form.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(i)</span></u><span
style='color:black'>         <u>Civil and Criminal Immunity for Patient
Representatives. – No person acting as a patient representative shall be
subject to criminal or civil liability for acting in good faith under this
section.</u>&quot;</span></p>

<p class=aBillSection><b><span style='color:black'>SECTION 2.1.(b)</span></b><span
style='color:black'>  By October 1, 2019, the Department of Health and Human
Services, in consultation with the Commission for Mental Health, Developmental
Disabilities, and Substance Abuse Services, the North Carolina Medical Board,
and the North Carolina Board of Pharmacy, shall develop and publish on its
Internet Web site a uniform opioid prescription and treatment opt out form that
complies with the requirements of G.S.&nbsp;90&#8209;21.17A, as enacted by
Section 2.1(a) of this act, in a format that can be downloaded and copied.</span></p>

<p class=aBillSection><b><span style='color:black'>SECTION 2.1.(c)</span></b><span
style='color:black'>  Subsection (b) of this section is effective when it
becomes law.</span></p>

<p class=aBase>&nbsp;</p>

<p class=aHeading>PART III. INSURANCE COVERAGE FOR NON&#8209;OPIOID PAIN
MANAGEMENT CARE.</p>

<p class=aBillSection><b><span style='color:black'>SECTION 3.1.(a)</span></b><span
style='color:black'>  Article 51 of Chapter 58 of the General Statutes is
amended by adding a new section to read:</span></p>

<p class=aSection><span style='color:black;font-weight:normal'>&quot;</span><u><span
style='color:black'>§ 58&#8209;51&#8209;56.  Coverage for non&#8209;opioid pain
management care.</span></u></p>

<p class=aMargin1><u><span style='color:black'>(a)</span></u><span
style='color:black'>        <u>Every health benefit plan offered by an insurer
must provide coverage for evidence&#8209;based non&#8209;opioid pain management
care. Evidence&#8209;based non&#8209;opioid pain management care includes at
least all of the following treatments:</u></span></p>

<p class=aBlock1><u><span style='color:black'>(1)</span></u><span
style='color:black'>        <u>Acupuncture.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(2)</span></u><span
style='color:black'>        <u>Chiropractic care.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(3)</span></u><span
style='color:black'>        <u>Massage therapy.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(4)</span></u><span
style='color:black'>        <u>Occupational therapy.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(5)</span></u><span
style='color:black'>        <u>Osteopathic manipulative treatment.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(6)</span></u><span
style='color:black'>        <u>Physical therapy.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(b)</span></u><span
style='color:black'>        <u>Evidence&#8209;based non&#8209;opioid pain
management care shall be considered a rehabilitation and habilitation service
under the Patient Protection and Affordable Care Act, P.L. 111&#8209;148, as
amended, and applicable corresponding regulations.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(c)</span></u><span
style='color:black'>        <u>Coverage for evidence&#8209;based non&#8209;opioid
pain management care offered under this section shall not be subject to annual
or lifetime numerical limits on visits for the treatment of pain.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(d)</span></u><span
style='color:black'>       <u>The amount of coinsurance, copayments, and
deductible for evidence&#8209;based non&#8209;opioid pain management care shall
be the same as the amount of coinsurance, copayments, and deductible for
primary care services.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(e)</span></u><span
style='color:black'>        <u>The amount of provider reimbursement by an
insurer for evidence&#8209;based non&#8209;opioid pain management care shall be
no less than seventy&#8209;five percent (75%) of the billing code rate.</u>&quot;</span></p>

<p class=aBillSection><b><span style='color:black'>SECTION 3.1.(b)</span></b><span
style='color:black'>  G.S.&nbsp;135&#8209;48.51 is amended by adding a new
subdivision to read:</span></p>

<p class=aBlock1><span style='color:black'>&quot;<u>(14)</u>    <u>G.S.&nbsp;58&#8209;51&#8209;56,
Coverage for non&#8209;opioid pain management care.</u>&quot;</span></p>

<p class=aBillSection><b><span style='color:black'>SECTION 3.1.(c)</span></b><span
style='color:black'>  Subsections (a) and (b) of this section become effective
October 1, 2019, and apply to health benefit plan contracts issued, renewed, or
amended on or after that date.</span></p>

<p class=aBase>&nbsp;</p>

<p class=aHeading>PART IV. EFFECTIVE DATE</p>

<p class=aBillSection><b><span style='color:black'>SECTION 4.1.</span></b><span
style='color:black'>  Except as otherwise indicated, this act becomes effective
January 1, 2020.</span></p>

</div>

</body>

</html>
